Anderson, M.A.; Walewska, R.; Hackett, F.; Kater, A.P.; Montegaard, J.; O’Brien, S.; Seymour, J.F.; Smith, M.; Stilgenbauer, S.; Whitechurch, A.;
et al. Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient Care. Cancers 2024, 16, 980.
https://doi.org/10.3390/cancers16050980
AMA Style
Anderson MA, Walewska R, Hackett F, Kater AP, Montegaard J, O’Brien S, Seymour JF, Smith M, Stilgenbauer S, Whitechurch A,
et al. Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient Care. Cancers. 2024; 16(5):980.
https://doi.org/10.3390/cancers16050980
Chicago/Turabian Style
Anderson, Mary Ann, Renata Walewska, Fidelma Hackett, Arnon P. Kater, Josie Montegaard, Susan O’Brien, John F. Seymour, Matthew Smith, Stephan Stilgenbauer, Ashley Whitechurch,
and et al. 2024. "Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient Care" Cancers 16, no. 5: 980.
https://doi.org/10.3390/cancers16050980
APA Style
Anderson, M. A., Walewska, R., Hackett, F., Kater, A. P., Montegaard, J., O’Brien, S., Seymour, J. F., Smith, M., Stilgenbauer, S., Whitechurch, A., & Brown, J. R.
(2024). Venetoclax Initiation in Chronic Lymphocytic Leukemia: International Insights and Innovative Approaches for Optimal Patient Care. Cancers, 16(5), 980.
https://doi.org/10.3390/cancers16050980
